MIRA INFORM REPORT

 

 

Report Date :

23.05.2007

 

IDENTIFICATION DETAILS

 

Name :

MEYER- BPC JOINT VENTURE COMPANY

 

 

Registered Office :

No. 6A3, National Road No. 60, Phu Khuong Ward, Ben Tre Town, Ben Tre Province

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2006

 

 

Date of Incorporation :

2001

 

 

Legal Form :

Joint Venture Company

 

 

Line of Business :

Manufacturing and trading pharmaceutical

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 


 

SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name
 
MEYER- BPC JOINT VENTURE COMPANY

Vietnamese name

 

CONG TY LIEN DOANH MEYER-BPC

Trade Name

 

MEYER –BPC CO

Type of Business

 

Joint venture company

Foundation

 

2001

Investment license No

 

2215/GP

Date of Issuance

 

August 20th, 2001

Place of Issuance

 

Planning and investment department of Ben Tre Province

Invested capital

 

1,500,000 USD

Legal capital

 

1,000,000 USD

Investment duration

 

30 years

Tax Code

 

1300337479

Total Employees

 

230 employees

Qualification

 

Fairly good

 

 

ADDRESS

 

Head Office

Address

 

No. 6A3, National Road No. 60, Phu Khuong Ward, Ben Tre Town, Ben Tre Province

Country

 

Vietnam

Tel

 

(84-75) 822428

Fax

 

(84-75) 817573

Email

 

meyerbpc@hcm.vnn.vn

 

 

DIRECTORS

 

1. NAME

 

Mr. DINH VAN BICH

Position

 

Director

Resident

 

Ben Tre Town, Ben Tre Province

Nationality

 

Vietnamese

 

2. NAME

 

Mr. NGUYEN VAN NON

Position

 

Deputy Director

Resident

 

Ben Tre Town, Ben Tre Province

Nationality

 

Vietnamese

 

3. NAME

 

Mr. HUYNH THIEN NGHIA

Position

 

Deputy Director

Resident

 

Ben Tre Town, Ben Tre Province

Nationality

 

Vietnamese

 

 

BUSINESS NATURE AND ACTIVITIES

 

The subject is specializing in manufacturing and trading pharmaceutical

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT: The subject imports materials and equipments from Italy, France, China and India

EXPORT: The subject does not export.

 

 

BANKERS

 

1. INVESMENT AND DEVELOPMENT BANK – BEN TRE BRANCH

Address

 

No. 21, Dong Khoi Street, Ward 3, Ben Tre Town, Ben Tre Province

Tel

 

84-75 829492

Fax

 

84-75 824964

 

 

SHAREHOLDERS

 
1. Name
 
BEN TRE PHARMACEUTICAL JOINT STOCK COMPANY

Address

 

No. 6A3, National Road No. 60, Phu Khuong Ward, Ben Tre Town, Ben Tre Province

Country

 

Vietnam

Tel

 

(84-75) 822429

Fax

 

(84-75) 817617

Website 
 
www.bepharco.com

Share

 

60 %

Value

 

600,000 USD

 

2. Name
 
MEYER PHARMACEUTICAL LTD
Country
 
Hong Kong

Share

 

40 %

Value

 

400,000 USD

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality

 

Above average

Liquidity

 

Normal

Previous Payments

 

Normal

Payment status

 

Above average

Past Financial Situation

 

Average

Current Financial Situation

 

Fairly good

Litigation Data

 

No recorded

Bankruptcy

 

No recorded

Public opinion

 

Fairly good

Payment Methods

 

Through its bank, T.T, D.P at sight

 

 

FINANCIAL DATA

 

BALANCE SHEET

Unit: 1,000,000 VND

Balance sheet date

31/12/2006

Number of weeks

52

ASSETS

A. Working assets & short-term Investment

26,305

I. Cash and cash equivalents

1,760

II. Short-term investment

0

 1. Short-term securities investment

0

 2. Other short-term investment

0

 3. Provision for short-term investment

0

III. Receivables

12,965

1. Receivables from customers

12,250

 2. Prepayment for providers

288

 3. Value-added tax deducted

426

 4. Internal receivables

0

 5. Other receivables

1

 6. Provision for bad receivables

0

IV. Inventory

11,519

 1. Purchased goods in transit

0

 2. Raw materials

11,519

 3. Instrument, tools

0

 4. Cost for production and business in process

0

 5. End products

0

 6. Goods

0

 7. Goods on consignment

0

 8. Provision for devaluation of stocks

0

V. Other current assets

61

 1. Advances

0

 2. Prepaid expenses

61

 3. Pending expenses for transfer

0

 4. Pending assets

0

 5. Mortgage, collateral and short run collateral

0

VI. Administrative

0

 1. Administrative expenses for previous year

0

 2. Administrative expenses for current year

0

B. Fixed assets & Long term investment

19,824

I.  Fixed assets

7,074

1. Tangible fixed assets

7,074

   + Original cost

9,860

   + Accumulated depreciation value

-2,786

2.  Financial leasing fixed assets

0

   + Original cost

0

   + Accumulated depreciation value

0

3. Intangible fixed assets

0

   + Original cost

0

   + Accumulated depreciation value

0

II. Long term investment

0

1. Long-term securities investment

0

2. Joint-venture capital contribution

0

3. Other long-term investment

0

4. Provision for long-term investment devaluation

0

III. Capital construction in process

12,750

IV. Other

0

TOTAL ASSETS

46,129

A. Payable loans

30,725

I. Short term payables

25,974

1. Short-term borrowings

13,988

2. Due long-term liabilities

0

3. Payables to supplier

11,687

4. Prepayment of buyer

0

5. Taxes and accounts dutiable

0

6. Employee payments

37

7. Internal payables

0

8. Other payables

262

II. Long term loans

4,219

1. Long-term borrowings

4,219

2. Long-term payables

0

III. Other payables

532

1. Payable expenses

532

2. Pending assets

0

3. Receipts long-term collateral and deposit

0

B. Owner’s Equity

15,404

I. Capital and Funds

15,413

1. Working capital

15,629

2. Differences from asset revaluation

0

3. Exchange rate differences

0

4. Development investment funds

0

5. Reserved funds

0

6. Retained profit

-216

7. Construction capital sources

0

II. Other administrative and fund sources

-9

1. Provident funds for unemployment

0

2. Reward and welfare funds

-9

3. Management funds of higher level

0

4. Functional operation funds

0

5. Fund sources formed by fixed assets

0

TOTAL LIABILITY AND EQUITY

46,129

 


 

PROFIT & LOSE ACCOUNT (INCOME STATEMENT)

 

Description

F.Y 2006

Total revenue

31,083

Deductions Items

499

- Discount

0

- Devaluation

0

- Return of sold goods

499

- Turnover tax, Luxury tax & Export tax

0

1. Net revenue

30,584

2. Cost of goods sold

30,114

3. Gross Profit

470

4. Sales expenses

0

5. Enterprise administrative expenses

5

6. Net income from business activities

465

Income from financial activities

27

Expenditure from financial activities

10

7. Net income from financial operation

17

Irregular income

86

Irregular expenditure

5

8. Irregular Profit

81

9. Total pre-tax profit

563

10. Income tax

0

11. After tax profit

563

 

 

FINANCIAL FACTORS

 

Description

F.Y 2006

Current Liquidity Ratio

1.01

Quick Liquidity Ratio

0.57

Inventory Circle

5.23

Average Receive Period

154.73

Utilizing Asset Performance

0.66

Liability / Total Asset (%)

66.61

Liability / Owner's Equity (%)

199.46

Income Before Tax / Total Asset (%) ROA

1.22

Income Before Tax / Owner's Equity (%) ROE

3.65

Income Before Tax / Total Revenue (%) NPM

1.81

Gross Profit / Total Revenue (%) GPM

1.51

 

 

INTERPRETATION

 

Meyer-BPC Joint Venture Company is a 60 %-40 % joint venture company between Ben Tre Pharmaceutical Joint Stock Company and Meyer Pharmaceutical Ltd.

 

The subject got invested license No. 2215/GP on August 20th, 2001 issued by Planning and investment department of Ben Tre Province. The plant was built at the beginning of 2003 and started operation since July of 2005.

 

Meyer-BPC Joint Stock Company is specializing in manufacturing and trading pharmaceutical, especially non-betalactam tablet, capsule and powder tablet.

 

After nearly two years of operation, the subject has produced about 70 kinds of products under the GMP, GLP, and GPS standard. Currently, the subject has four distributor branches in Hochiminh City, Hanoi City, Da Nang City and Can Tho City, more than detail shops and more than 360 agents in all over the country.

 

The subject has good business relationship with partners and is distributor of foreign firms such as Egis, Helm, AG, Cipla, Raptakos, Meyer, Gedeon Richter, Lactose New Zealand, Neo Unicap, Aceto PTE which are belonged to national such as Australia, Hungary, India, Korea, New Zealand, Germany, Thailand, China and Singapore.

The subject has just been found and operation not long time but it has prospect of development and operation.

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions